Show simple item record

dc.contributor.authorFiner, Sen_US
dc.contributor.authorRobb, Pen_US
dc.contributor.authorCowan, Ken_US
dc.contributor.authorDaly, Aen_US
dc.contributor.authorShah, Ken_US
dc.contributor.authorFarmer, Aen_US
dc.date.accessioned2018-07-16T07:39:56Z
dc.date.available2018-02-22en_US
dc.date.issued2018-07en_US
dc.date.submitted2018-04-03T11:33:51.531Z
dc.identifier.urihttp://qmro.qmul.ac.uk/xmlui/handle/123456789/42144
dc.description.abstractAIMS: To describe processes and outcomes of a priority setting partnership to identify the 'top 10 research priorities' in Type 2 diabetes, involving people living with the condition, their carers, and healthcare professionals. METHODS: We followed the four-step James Lind Alliance Priority Setting Partnership process which involved: gathering uncertainties using a questionnaire survey distributed to 70 000 people living with Type 2 diabetes and their carers, and healthcare professionals; organizing the uncertainties; interim priority setting by resampling of participants with a second survey; and final priority setting in an independent group of participants, using the nominal group technique. At each step the steering group closely monitored and guided the process. RESULTS: In the first survey, 8227 uncertainties were proposed by 2587 participants, of whom 18% were from black, Asian and minority ethnic groups. Uncertainties were formatted and collated into 114 indicative questions. A total of 1506 people contributed to a second survey, generating a shortlist of 24 questions equally weighted to the contributions of people living with diabetes and their carers and those of healthcare professionals. In the final step the 'top 10 research priorities' were selected, including questions on cure and reversal, risk identification and prevention, and self-management approaches in Type 2 diabetes. CONCLUSION: Systematic and transparent methodology was used to identify research priorities in a large and genuine partnership of people with lived and professional experience of Type 2 diabetes. The top 10 questions represent consensus areas of research priority to guide future research, deliver responsive and strategic allocation of research resources, and improve the future health and well-being of people living with, and at risk of, Type 2 diabetes.en_US
dc.description.sponsorshipDiabetes UKen_US
dc.format.extent862 - 870en_US
dc.languageengen_US
dc.relation.ispartofDiabet Meden_US
dc.rightsThis is an open access article under the terms of the Creative Commons Attribution‐NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
dc.subjectCaregiversen_US
dc.subjectDiabetes Mellitus, Type 2en_US
dc.subjectHealth Personnelen_US
dc.subjectHumansen_US
dc.subjectQuality Improvementen_US
dc.subjectQuality of Lifeen_US
dc.subjectResearchen_US
dc.subjectSelf Careen_US
dc.subjectStakeholder Participationen_US
dc.subjectSurveys and Questionnairesen_US
dc.subjectUnited Kingdomen_US
dc.titleSetting the top 10 research priorities to improve the health of people with Type 2 diabetes: a Diabetes UK-James Lind Alliance Priority Setting Partnership.en_US
dc.typeArticle
dc.rights.holder© 2018 The Authors. Diabetic Medicine published by John Wiley & Sons Ltd on behalf of Diabetes UK.
dc.identifier.doi10.1111/dme.13613en_US
pubs.author-urlhttps://www.ncbi.nlm.nih.gov/pubmed/29485717en_US
pubs.issue7en_US
pubs.notesNo embargoen_US
pubs.notesOpen accessen_US
pubs.publication-statusPublisheden_US
pubs.volume35en_US
dcterms.dateAccepted2018-02-22en_US


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record